Xenical is an innovative weight loss medication, ideal for those on a journey to reduce their weight. Its active ingredient, Orlistat, is specially formulated to bind with dietary fat, reducing the body's absorption of fat by approximately one-third. This unique action assists in more effective weight loss, making Xenical a preferred choice for individuals with a Body Mass Index (BMI) over 30, or over 28 with additional health concerns like high blood pressure or diabetes.

Key Features:

• Contains Orlistat, a proven fat-binding drug.
• Reduces fat absorption from food by about 30%.
• Clinically proven to aid in weight loss and maintenance.
• Suitable for individuals with a BMI of over 30, or over 28 with additional health conditions.
• Easy to use: one capsule three times a day with meals.
• Trusted worldwide, with millions of users.

Frequently Asked Questions (FAQs):

Is this an over-the-counter medication?

No, this is a prescription-only medication that can be purchased over the counter via a private service called PGD (Patient Group Direction).

What are the service inclusion criteria?

Xenical is suitable for a specific group of individuals who meet the following criteria:

1. Age Range: People aged between 18 and 65 years.
2. BMI Threshold: People with an initial Body Mass Index (BMI) of 30 kg/m² or greater qualify for Xenical.
3. Failed Previous Weight Management Attempts: This treatment is intended for people for whom prior attempts at weight reduction, including supervised diet, behaviour modification, and increased physical activity, have not resulted in a practical and sustainable reduction in weight.
4. Weight-Related Comorbidities: People with an initial BMI of 28 kg/m² or greater are also eligible if they have at least one weight-related comorbidity. These comorbidities may include, but are not limited to:
   • Controlled Hypertension
   • Dyslipidaemia
   • Obstructive sleep apnoea
   • Type 2 diabetes mellitus

Our service does not include a prescription. Instead, your treatment will be supplied under a legal framework called Patient Group Direction (PGD), and the process will follow these steps:

1. Complete a health questionnaire:

Provide detailed information about your health, medical history, and previous weight management attempts.

2. Pharmacist assessment:

Our pharmacist will review your responses and may reach out via phone or video call to confirm your suitability for Mounjaro.

3. Private consultation:

All consultations are private and confidential. This gives you the opportunity to ask questions and ensure Mounjaro is the right choice for your needs.

4. All-inclusive pricing:

The price you pay includes the consultation fee, with no hidden costs.

5. Identity verification:

You'll need to provide identification during the consultation to confirm that you are the intended user. This is required only during your first order.

6. Photographic evidence request:

You’ll be asked to submit photographic evidence of your weight, height, and relevant medical history to ensure safe and accurate consultation.

Purchasing this medication does not guarantee its supply. The decision if this medication is right for you will be made together with the pharmacist during your consultation, and ultimately the decision to supply the medication is with the pharmacist. Any orders found not suitable will be refunded.

Active ingredient: 120 mg orlistat

Other ingredients:

Capsule filling: microcrystalline cellulose (E460), sodium starch glycolate (type A), povidone (E1201), sodium laurilsulfate, talc. Capsule shell: gelatine, indigo carmine (E132), titanium dioxide (E171), edible printing ink (black iron oxide, ammonia solution concentrated, potassium hydroxide, shellac, propylene glycol).

One 120 mg capsule should be taken orally with water immediately before, during or up to one hour after each main meal, for a maximum of three times a day.

A tablet should not be taken if a meal is missed or contains no fat.

• Not recommended with ciclosporin.
• Adherence to dietary recommendations is essential.
• High-fat diets increase the risk of gastrointestinal side effects.
• Additional contraception is advised during severe diarrhoea.
• Risk of hyperoxaluria and oxalate nephropathy, potentially leading to renal failure.
• Possible hypothyroidism or reduced control of it; may affect iodine salts/levothyroxine absorption.
• May decrease absorption of antiepileptic drugs, leading to convulsions.
• Potential reduction in absorption and efficacy of HIV antiretrovirals.
• Contains less than 1 mmol sodium per capsule ('sodium-free').

Contraindications

• Hypersensitivity to active substance or excipients.
• Chronic malabsorption syndrome.
• Cholestasis.
• Breast-feeding.